supp.fit

Barley Grass

15 benefits mapped to clinical evidence across supplements.

Dose per serving from products

44 products in our catalogue print how much Barley Grass a serving holds.

Most common: 250 mg to 500 mg, 25% of 44 products.

Dose per servingProducts
10 mg or less
3
10 mg to 25 mg
2
25 mg to 50 mg
7
50 mg to 100 mg
9
100 mg to 250 mg
0
250 mg to 500 mg
11
500 mg to 1 g
10
over 1 g
2

Benefit Evidence

Metabolism
Moderate

Glucose/insulin ↓, fiber + fermentation

LDL/total cholesterol ↓ ~10-15%

757 people

LDL/TC ↓

Skin blood flow ↑

527 people
Blood sugar
Moderate

Lower post-meal glucose

↓ glucose/insulin peaks

More fermentation, lower HGP

360 people

↓ appetite/intake

↓ waist/fat

↓ glucose/LDL

377 people

Fiber digestion +17%

Cholesterol/mood/glycemia lower

251 people

P,Ca uptake↑

Zn uptake↑

301 people

↓Inflammation markers

↑Immune cells

272 people
Inflammation
Moderate

Inflammation ↓ IL-6/TNF-α

CRP/ESR ↓; symptoms ↓

Gut bacteria ↑; SCFAs ↑

272 people

Lower fatigue 19%

Less fatigue symptoms

255 people

Stool + fermentation

Bacteria + SCFAs

179 people

Mood/depression -44%

Sleep/mood/focus improved

149 people

Glycemia/lipids/fat: -6.3 kg

Milk volume: +1830 mL

COVID stay/inflammation: -4.5 days

180 people

↓ Genotoxicity

↑ Bile acid/SCFA excretion

99 people

↓ genotoxicity

↓ cytotoxicity

69 people

Reduced bloating (-)

More stool bulk (+33%)

65 people

Research sources

Metabolism (13)
  1. [Effects of barley flake on metabolism of glucose and lipids in the patients with impaired fasting glucose]

    PubMed ID: 24218874

    Three‑month trial in IFG patients showed significant improvements in fasting glucose, insulin and lipids with barley flakes.

  2. Cholesterol-lowering effect of barley bran flour and oil

    PubMed ID: 8270757

    Barley bran/flour or oil added to cholesterol‑lowering diet further reduced total and LDL cholesterol in humans — strong human metabolic support (lipids).

  3. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial

    PubMed ID: 18074229

    12‑week RCT: high–beta‑glucan barley lowered LDL/total cholesterol and reduced visceral fat and waist circumference.

  4. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women

    PubMed ID: 17445284

    Large RCT: concentrated barley beta‑glucan produced clinically meaningful LDL and total-cholesterol reductions—strong metabolic benefit.

  5. Barley cultivar, kernel composition, and processing affect the glycemic index

    PubMed ID: 22833662

    Human data showing cultivar/processing markedly change barley's glycaemic impact — relevant to metabolic effects.

  6. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women

    PubMed ID: 24063257

    Barley+legume diet improved lipids and cardiometabolic markers in overweight women—metabolic support evidence.

  7. Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics

    PubMed ID: 30046942

    Short-term barley-kernel intake improved next-morning glucose tolerance and lowered insulin responses; supports metabolic benefit.

  8. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals

    PubMed ID: 29872803

    High‑MW β‑glucan increased bile acid excretion and SCFA—mechanisms relevant to cholesterol and metabolic regulation.

  9. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development

    PubMed ID: 30396006

    4‑week 6 g β‑glucan bread modestly lowered total cholesterol and altered SCFA/microbiome—supports metabolic modulation.

  10. Effect of Barley on Postprandial Blood Glucose Response and Appetite in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

    PubMed ID: 39599684

    Barley‑derived fiber drink significantly reduced postprandial glucose and insulin in a large RCT—clear metabolic support.

  11. Barley-Based Cereals Enhance Metabolic Health and Satiety in Overweight Korean Adults: A Randomized Trial

    PubMed ID: 40944189

    Barley‑based breakfast replacement reduced body fat, waist and improved HOMA‑IR in overweight adults—meaningful metabolic outcome.

  12. High-amylose barley bread improves postprandial glycemia compared to regular barley and wheat bread in subjects with or without type 2 diabetes

    PubMed ID: 40691269

    High‑amylose barley bread sharply lowered postprandial glucose, insulin and GIP in T2D and non‑T2D—robust metabolic effects.

  13. The effect of barley savigh consumption on blood sugar among pre-diabetic postmenopausal women

    PubMed ID: 40604206

    Barley product lowered fasting and 2‑hr postprandial glucose in prediabetic postmenopausal women—clinical metabolic improvement.

Blood circulation (8)
  1. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial

    PubMed ID: 18074229

    LDL and total-cholesterol reductions plus reduced visceral fat and waist circumference suggest improved cardiometabolic risk.

  2. Cholesterol-lowering effect of barley bran flour and oil

    PubMed ID: 8270757

    Randomized human trial: barley bran flour or barley oil added to a lipid‑lowering diet further reduced total and LDL cholesterol — strong human evidence for circulatory support.

  3. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development

    PubMed ID: 30396006

    Modest total cholesterol reduction and gut‑mediated effects could contribute to long‑term vascular benefit.

  4. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism

    PubMed ID: 29115200

    Cholesterol lowering with increased bile acid synthesis supports cardiovascular/circulatory risk-factor improvement.

  5. High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults

    PubMed ID: 26936139

    Daily 3 g HMW barley β-glucan modestly lowered total cholesterol in mildly hypercholesterolemic adults—relevant to cardiovascular risk/circulation.

  6. [Effects of barley flake on metabolism of glucose and lipids in the patients with impaired fasting glucose]

    PubMed ID: 24218874

    Barley‑flake consumption improved lipids (TC, LDL) in IFG patients—supports circulation/vascular risk reduction.

  7. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women

    PubMed ID: 24063257

    Barley+legume dietary intervention in overweight women reduced total and LDL cholesterol and apoB—relevant to cardiovascular/circulatory risk.

  8. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women

    PubMed ID: 17445284

    Significant LDL and total-cholesterol reductions (dose-dependent) support cardiovascular/circulatory health.

Blood sugar (7)
  1. [Effects of barley flake on metabolism of glucose and lipids in the patients with impaired fasting glucose]

    PubMed ID: 24218874

    Three‑month RCT in IFG patients showed substantial reductions in fasting glucose, insulin and HbA1c proxies with barley flakes.

  2. Effect of Barley on Postprandial Blood Glucose Response and Appetite in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

    PubMed ID: 39599684

    Large RCT of barley‑derived fiber drink showed marked reductions in postprandial glucose AUC and insulin.

  3. Barley-Based Cereals Enhance Metabolic Health and Satiety in Overweight Korean Adults: A Randomized Trial

    PubMed ID: 40944189

    Six‑week barley cereal intervention improved short‑term glycemia (glycated albumin) and insulin sensitivity.

  4. High-amylose barley bread improves postprandial glycemia compared to regular barley and wheat bread in subjects with or without type 2 diabetes

    PubMed ID: 40691269

    High‑amylose barley bread substantially lowered postprandial glucose and insulin in both T2D and non‑T2D—robust acute glycemic control.

  5. The effect of barley savigh consumption on blood sugar among pre-diabetic postmenopausal women

    PubMed ID: 40604206

    Barley product lowered fasting and 2‑hr postprandial glucose in prediabetic women after 4 weeks.

  6. Barley cultivar, kernel composition, and processing affect the glycemic index

    PubMed ID: 22833662

    Cultivar/processing strongly alter barley's glycaemic index—directly relevant to blood sugar control.

  7. Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics

    PubMed ID: 30046942

    Short-term barley-kernel intake improved next-morning glucose tolerance and lowered insulin AUCs—strong support for glucose regulation.

Weight management (6)
  1. Effect of Barley on Postprandial Blood Glucose Response and Appetite in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

    PubMed ID: 39599684

    Barley fiber drink lowered postprandial glucose/insulin and reduced short‑term hunger—supports weight management behaviorally and metabolically.

  2. Effects of high β-glucan barley on visceral fat obesity in Japanese individuals: A randomized, double-blind study

    PubMed ID: 28870472

    12-week substitution of high β-glucan barley for rice produced modest but significant reductions in visceral fat and body weight, especially in higher‑VFA subjects.

  3. [Effects of barley flake on metabolism of glucose and lipids in the patients with impaired fasting glucose]

    PubMed ID: 24218874

    Barley‑flake intervention improved metabolic markers in IFG; metabolic improvements can support weight management efforts.

  4. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial

    PubMed ID: 18074229

    12‑week RCT: replacing rice with high–beta‑glucan barley reduced visceral fat, BMI and waist circumference—strong evidence for weight/central adiposity benefit.

  5. High-amylose barley bread improves postprandial glycemia compared to regular barley and wheat bread in subjects with or without type 2 diabetes

    PubMed ID: 40691269

    Large reductions in postprandial glucose/insulin may contribute to improved weight control over time despite no direct weight outcomes in that acute study.

  6. Barley-Based Cereals Enhance Metabolic Health and Satiety in Overweight Korean Adults: A Randomized Trial

    PubMed ID: 40944189

    Six‑week barley cereal reduced percent body fat and waist circumference and improved insulin sensitivity—strong weight‑related evidence.

Nutrition source (5)
  1. Barley-Based Cereals Enhance Metabolic Health and Satiety in Overweight Korean Adults: A Randomized Trial

    PubMed ID: 40944189

    Barley cereal replaced breakfast and improved body composition and glycemia—suggests beneficial nutritional profile.

  2. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women

    PubMed ID: 24063257

    Functional barley+legume diet improved cardiometabolic markers and provided a nutrient‑dense intervention in overweight women.

  3. Effect of Talbinah food consumption on depressive symptoms among elderly individuals in long term care facilities, randomized clinical trial

    PubMed ID: 23493965

    Talbinah increased calorie, zinc and magnesium intake and improved mood in elderly—clear nutrient‑boost evidence.

  4. Barley malt-based composition as a galactagogue - a randomized, controlled trial in preterm mothers

    PubMed ID: 33751522

    Barley malt increased milk output in lactating mothers, effectively boosting nutrient delivery to infants.

  5. The effects of waxy barley on defecation, sleep, mental health, and quality of life: a randomized double-blind parallel-group comparison study

    PubMed ID: 40336123

    Waxy barley increased daily fiber intake and improved bowel habits—practical evidence of nutrient/dietary quality boost.

Nutrient uptake (4)
  1. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals

    PubMed ID: 29872803

    Increased SCFA production and bile acid excretion from β‑glucan affect intestinal environment and may enhance nutrient processing/absorption.

  2. Effect of microbial phytase on phosphorus digestibility in non-heat-treated and heat-treated wheat-barley pig diets

    PubMed ID: 23365331

    Microbial phytase restored phosphorus availability reduced by heat treatment in pig/barley diets—animal evidence for improved mineral availability.

  3. Growth performance and nutrient digestibilities in nursery pigs receiving varying doses of xylanase and β-glucanase blend in pelleted wheat- and barley-based diets

    PubMed ID: 23365293

    Adding xylanase/β‑glucanase to pig wheat/barley diets improved ileal digestibility of energy and amino acids—strong animal evidence for enhanced nutrient availability.

  4. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development

    PubMed ID: 30396006

    Microbiome shifts and increased SCFA after barley bread could influence nutrient absorption and host metabolism.

Immune support (4)
  1. Effects of a Novel Barley-Based Formulation on Allergic Rhinitis: A Randomized Controlled Trial

    PubMed ID: 30843497

    Barley‑based product reduced allergic rhinitis symptoms and lowered total IgE in a randomized trial—direct immune‑related clinical outcome.

  2. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis

    PubMed ID: 21367884

    Germinated barley foodstuff reduced serum inflammatory cytokines (IL‑6, IL‑8, TNF‑α) in ulcerative colitis, implying immune modulation.

  3. Effects of Chronic Barley Consumption on Upper Respiratory Tract Symptoms in Japanese Healthy Adults: A Randomized, Parallel-Group, Controlled Trial

    PubMed ID: 39064742

    Cooked waxy barley reduced URT symptom days and increased NK cell activity in low‑baseline subjects—clinical immune enhancement.

  4. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial

    PubMed ID: 35179770

    Daily Persian barley water shortened hospital stay and lowered inflammatory markers in COVID‑19 patients—strong clinical immune/inflammatory effects.

Inflammation (4)
  1. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial

    PubMed ID: 35179770

    Barley water reduced CRP and ESR and shortened hospital stay in COVID patients—clear anti‑inflammatory clinical signals.

  2. Effects of a Novel Barley-Based Formulation on Allergic Rhinitis: A Randomized Controlled Trial

    PubMed ID: 30843497

    Barley formulation lowered IgE and allergy symptoms in rhinitis—immune‑modulating/anti‑inflammatory effect.

  3. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis

    PubMed ID: 21367884

    Germinated barley foodstuff significantly reduced systemic inflammatory cytokines in ulcerative colitis patients.

  4. Effects of Chronic Barley Consumption on Upper Respiratory Tract Symptoms in Japanese Healthy Adults: A Randomized, Parallel-Group, Controlled Trial

    PubMed ID: 39064742

    Reduced URT symptom days and improved NK activity suggest dampening of symptomatic inflammation in some subjects.

Energy & Fatigue (4)
  1. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial

    PubMed ID: 35179770

    Barley water shortened hospital stays and lowered fever/inflammation, which likely reduced illness‑related fatigue.

  2. Effects of Chronic Barley Consumption on Upper Respiratory Tract Symptoms in Japanese Healthy Adults: A Randomized, Parallel-Group, Controlled Trial

    PubMed ID: 39064742

    Barley intake reduced cumulative days with fatigue and improved mood/NK activity—direct reduction in tiredness reported.

  3. The effects of waxy barley on defecation, sleep, mental health, and quality of life: a randomized double-blind parallel-group comparison study

    PubMed ID: 40336123

    Improved sleep quality and depressive symptoms in RCT plausibly reduce daytime tiredness.

  4. High-amylose barley bread improves postprandial glycemia compared to regular barley and wheat bread in subjects with or without type 2 diabetes

    PubMed ID: 40691269

    Markedly reduced postprandial glucose/insulin may support steadier energy and reduced crashes after meals.

Digestive support (4)
  1. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development

    PubMed ID: 30396006

    Barley β‑glucan altered fecal SCFA and microbiota in metabolic‑risk subjects, implying improved gut function.

  2. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis

    PubMed ID: 21367884

    Germinated barley foodstuff reduced intestinal inflammation markers in ulcerative colitis patients, implying better GI comfort.

  3. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals

    PubMed ID: 29872803

    High‑MW barley β‑glucan increased fecal SCFAs and bile acid excretion—consistent mechanistic support for improved gut fermentation and comfort.

  4. The effects of waxy barley on defecation, sleep, mental health, and quality of life: a randomized double-blind parallel-group comparison study

    PubMed ID: 40336123

    Waxy barley increased defecation frequency and improved stool form in a randomized trial—direct clinical evidence of digestive benefit.

Mental clarity (3)
  1. The effects of waxy barley on defecation, sleep, mental health, and quality of life: a randomized double-blind parallel-group comparison study

    PubMed ID: 40336123

    Waxy barley improved sleep (PSQI) and depressive symptoms (PHQ‑9) in RCT—likely to support mental clarity and cognition indirectly.

  2. Effect of Talbinah food consumption on depressive symptoms among elderly individuals in long term care facilities, randomized clinical trial

    PubMed ID: 23493965

    Talbinah (barley‑based) reduced depression scores substantially in elderly institutionalized residents—supports mood/mental state.

  3. Effects of Chronic Barley Consumption on Upper Respiratory Tract Symptoms in Japanese Healthy Adults: A Randomized, Parallel-Group, Controlled Trial

    PubMed ID: 39064742

    Barley intake improved some mood scores (TMD) alongside reduced URT symptoms—supports mental well‑being.

Illness recovery (2)
  1. Barley malt-based composition as a galactagogue - a randomized, controlled trial in preterm mothers

    PubMed ID: 33751522

    Barley‑malt supplement increased expressed milk volume in mothers of preterm infants—supports postpartum nutritional recovery and lactation.

  2. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial

    PubMed ID: 35179770

    Shorter hospital stay and reduced inflammatory markers in COVID suggest improved clinical recovery with barley water adjunct.

Detoxification (2)
  1. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals

    PubMed ID: 29872803

    Increased fecal bile acid excretion suggests enhanced removal of cholesterol‑derived/intestinal metabolites—mechanistic detox relevance.

  2. Impact of β-glucan on the Fecal Water Genotoxicity of Polypectomized Patients

    PubMed ID: 27043932

    Decreased fecal water genotoxicity after 12 weeks of β-glucan–enriched bread suggests a detoxifying/colon-protective effect.

Antioxidant (1)
  1. Impact of β-glucan on the Fecal Water Genotoxicity of Polypectomized Patients

    PubMed ID: 27043932

    12-week β-glucan–enriched bread reduced fecal water genotoxicity (colon-protective biomarker), consistent with a protective effect relevant to oxidative/genotoxic stress.

Bloating & gas (1)
  1. The effects of waxy barley on defecation, sleep, mental health, and quality of life: a randomized double-blind parallel-group comparison study

    PubMed ID: 40336123

    Improved stool frequency and form implies reduced GI discomfort and likely less bloating.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Barley Grass

Search all

486 products whose verified label declares Barley Grass — not every bottle that mentions it in a title.